Subsequent research using an in vitro model of pancreatic cancer has confirmed these clinical observations and thus, the tumor-suppressing and -promoting potentials of IRF-1 and IRF-2, respectively [96]. The gene discussed is IRF2; the disease is familial pancreatic carcinoma.